Annual Report for the year ended 30 June 2009
OUR GROUP IN BRIEF
Our global footprint
Healthcare for life
Group overview
Highlights, achievements and key facts
Financial highlights
Sustainability highlights and recognition
Aspen as an investment
Our Group at a glance
Ten-year review
Therapeutic catagories
OUR REVIEWS
Chairman’s report
Group Chief Executive’s report
Financial review
BUSINESS REVIEW
South African business
International business
SUSTAINABILITY AND GOVERNANCE
Directorate
Sustainability report
Transformation report
Corporate social investment report
Value added statement
Corporate governance report
GROUP FINANCIAL STATEMENTS
Statement of responsibility by the Board of Directors
Independent auditors’ report
Certificate of the Company Secretary
Directors’ report
Group statement of financial position
Group statement of comprehensive income
Group statement of changes in equity
Group statement of cash flows
Group notes to statement of cash flows
Accounting policies
Significant judgements and estimates
Finalisation of PharmaLatina acquisition accounting
Notes to the Group annual financial statements
Company statement of financial position
Company statement of comprehensive income
Company statement of changes in equity
Company statement of cash flows
Company notes to the statement of cash flows
Notes to the Company annual financial statements
Group currency conversion (unaudited) – annexure 1
Share statistics (unaudited) – annexure 2
Specific repurchase of treasury shares
Notice of agm
Form of proxy
Administration and shareholders' diary
Abbreviations and definitions
Products depicted
search
|
|
print
|
email
|
downloads
Notes to the Group annual financial statements
1. PROPERTY, PLANT AND EQUIPMENT
2. GOODWILL
3. INTANGIBLE ASSETS
4. INVESTMENTS IN ASSOCIATES
5. PREFERENCE SHARE INVESTMENT
6. OTHER NON-CURRENT FINANCIAL
RECEIVABLES
7. DEFERRED TAX
8. INVENTORIES
9. TRADE AND OTHER RECEIVABLES
10. DERIVATIVE FINANCIAL INSTRUMENTS
11. CASH AND CASH EQUIVALENTS
12. SHARE CAPITAL AND SHARE PREMIUM
13.
TREASURY SHARES
14. SHARE-BASED COMPENSATION RESERVE
15. PREFERENCE SHARE CAPITAL
16. MINORITY INTERESTS
17. BORROWINGS
18. DEFERRED-PAYABLES
19. DEFERRED REVENUE
20. RETIREMENT BENEFIT OBLIGATIONS
21.
TRADE AND OTHER PAYABLES
22.
FINANCIAL LIABILITY AT AMORTISED COST
23. DERIVATIVE FINANCIAL INSTRUMENTS
24. REVENUE
25. OPERATING PROFIT
26. EXPENSES BY NATURE
27. DIRECTORS AND EMPLOYEES
28. INVESTMENT INCOME
29. FINANCING COSTS
30. TAX
31. EARNINGS PER SHARE
32. CAPITAL DISTRIBUTION PER SHARE
33. PROFIT FOR THE YEAR FROM
DISCONTINUED OPERATIONS
34. COMMITMENTS UNDER LEASES
35. CONTINGENT LIABILITIES
36. FINANCIAL RISK MANAGEMENT
37. ACQUISITIONS
38. RELATED PARTY TRANSACTIONS
39. IMPAIRMENT TESTS FOR GOODWILL
AND INDEFINITE USEFUL LIFE INTANGIBLE ASSETS
40. SEGMENTAL ANALYSIS
Back to top